RK

Rakesh Kuzhikkate

Active Director Director DIN 09415401
DIN 09415401 First appointment Nov 2021 Primary industry Non-Profit Organizations
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Rakesh Kuzhikkate

Data last updated:

Rakesh Kuzhikkate is a Director at Golden-Sparrow Pharmaceuticals Private Limited (since 2021). The company operates in Non-Profit Organizations.

DIN 09415401
Primary Designation Director
Industry Non-Profit Organizations
First Appointment 26 Nov 2021
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Nov 20212021Active

Board colleagues of Rakesh Kuzhikkate

NameDINCompanyDesignation
Vipin Vasudevan09415402Golden-Sparrow Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Golden-Sparrow Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rakesh Kuzhikkate

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rakesh Kuzhikkate

Rakesh Kuzhikkate currently holds 1 directorship: Golden-Sparrow Pharmaceuticals Private Limited (Director, since 26 Nov 2021).

Rakesh Kuzhikkate was first appointed on 26 Nov 2021 as Director at Golden-Sparrow Pharmaceuticals Private Limited.

The current boards of Rakesh Kuzhikkate's companies include Vipin Vasudevan (Golden-Sparrow Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available